"Everything is not right anymore": Buprenorphine experiences in an era of illicit fentanyl
- PMID: 31563098
- PMCID: PMC6914257
- DOI: 10.1016/j.drugpo.2019.09.003
"Everything is not right anymore": Buprenorphine experiences in an era of illicit fentanyl
Abstract
Background: Conducted in the Dayton Metropolitan area of Southwestern Ohio, this qualitative study explores the self-treatment practices of people who use illicit opioids (PWUIO) amidst the new risk environment produced by illicit, non-pharmaceutical fentanyl (NPF). We explore local perceptions of the presence of NPF in the Dayton area, and how this has both positively and negatively impacted practices of non-prescribed buprenorphine use among PWUIO.
Methods: This study analyzes qualitative data from 63 interviews conducted between October 2018 and June 2019. Participants were selected from a larger longitudinal study on non-prescribed buprenorphine use among individuals with opioid use disorder. Qualitative interviews were transcribed in their entirety, and their transcriptions were analyzed using NVivo software, drawing on a mix of thematic and inductive coding.
Results: Interview respondents ranged from 19 to 70 years old, with a mean age of 38.9 years. 54% of them were male, and 85.7% identified as non-Hispanic White. 98.4% of the sample had used heroin, and 93.7% of the sample reported use of NPF. Participants agreed NPF dominated the illicit opioids market in the area, and was perceived as both dangerous and desirable. The domination of NPF and associated overdose experiences prompted some to seek positive change and initiate self-treatment with non-prescribed buprenorphine. For others, NPF sabotaged established practices of harm reduction, as unanticipated experiences of precipitated withdrawals prompted some participants to give up non-prescribed buprenorphine use as a tactic of self-treatment.
Discussion: The changing nature of heroin/NPF necessarily gives rise to new beliefs surrounding self-treatment attempts, treatment seeking behaviors, and harm reduction practices. While buprenorphine treatment continues to offer promising results for treating opioid use disorders, it is urgent to reconsider how the unpredictable biochemical mixture of NPFs circulating on the streets today may impact the initiation and success of treatment.
Keywords: Buprenorphine; Fentanyl; Illicit fentanyl; Non-pharmaceutical fentanyl; Non-prescribed buprenorphine; Qualitative analysis; Self-treatment.
Copyright © 2019 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declarations of interest
none.
References
-
- Allen B and Harocopos A (2016). Non-Prescribed Buprenorphine in New York City: Motivations for Use, Practices of Diversion, and Experiences of Stigma. Journal of Substance Abuse Treatment, 70, 81–86. - PubMed
-
- Arfken CL, Johanson CE, di Menza S, & Schuster CR (2010). Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians. Journal of Substance Abuse Treatment, 39(2), 96–104. - PubMed
-
- Armenian P, Vo KT, Barr-Walker J, & Lynch KL (2018). Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review. Neuropharmacology, 134, 121–132. - PubMed
-
- Baselt RC (2011). Disposition of Toxic Drugs and Chemicals in Man, Ninth Edition Biomedical Publications, Seal Beach, California.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical